V
Viridian Therapeutics, Inc. (VRDN)
NCM – Real Time Price. Currency in USD
16.86
-0.34 (-1.98%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
16.86
-0.34 (-1.98%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 15.15 | 6.05 | 10 | |
| Quick ratio | 15.15 | 5.63 | 10 | |
| Debt to Equity | 0.08 | 0.30 | 9.0 | |
| Debt to Assets | 0.06 | 1.04 | 9.0 | |
| Interest coverage | -33.56 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2M | 314K | 302K | 71M | 71M |
| Gross Profit | 1M | -1M | -938K | 70M | 70M |
| Operating Income | -134M | -254M | -299M | -363M | -386M |
| Net Income | -130M | -238M | -209M | -282M | -342M |
| EBITDA | -134M | -253M | -298M | -362M | -385M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 12749.85 | 2.51 | 7.0 |
| Next quarter | -77.53 | -179.81 | 1.0 |
| Current year | -20.41 | -12.76 | 1.0 |
| Next year | 380.84 | 38.67 | 10 |
| Weighted average score | 4.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.82 | -2.86 | 16.67 | -389.03 | 4.0 |
| Y/Y | 95.83 | -20.69 | -3.44 | -29.04 | 3.3 |
| 3y average | 7757.95 | -35.3 | 3.28 | -46.81 | 4.0 |
| 5y average | 4683.17 | -28.23 | 25.55 | -59.38 | 5.5 |
| Weighted average score | 4.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $176.3M significantly exceed its total debt $51.2M, ensuring strong financial flexibility
Total current assets $784.7M exceed Total current liabilities $51.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-33.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$119.7M limits the company's ability to reinvest or pay down debt